Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$22.7K Buy
71
+1
+1% +$290 0.01% 135
2025
Q2
$21.9K Hold
70
0.01% 140
2025
Q1
$19.8K Sell
70
-1
-1% -$295 0.01% 160
2024
Q4
$18.5K Hold
71
0.01% 160
2024
Q3
$22.7K Buy
71
+1
+1% +$327 0.01% 136
2024
Q2
$21.9K Hold
70
0.01% 141
2024
Q1
$19.8K Buy
70
+1
+1% +$293 0.01% 161
2023
Q4
$19.9K Buy
69
+1
+1% +$272 0.01% 143
2023
Q3
$18.4K Hold
68
0.01% 148
2023
Q2
$15.1K Buy
68
+1
+1% +$232 0.01% 160
2023
Q1
$16.3K Hold
67
0.01% 152
2022
Q4
$17.5K Buy
67
+1
+2% +$268 0.01% 134
2022
Q3
$14.9K Hold
66
0.01% 139
2022
Q2
$16K Hold
66
0.01% 134
2022
Q1
$15.9K Hold
66
0.01% 135
2021
Q4
$14.8K Buy
+66
New +$13.9K 0.01% 133

Other funds holding AMGN

WFA Asset Management's AMGN Position: Q3 2025 in Review

WFA Asset Management increased its Amgen (AMGN) stake by 1.4% in Q3 2025, buying an estimated $290 and bringing the position to 71 shares worth $22.7K. The position accounts for 0.01% of the portfolio, ranked #135.

WFA Asset Management first reported a position in AMGN in Q4 2021 and has held it in 16 quarters since. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • WFA Asset Management held 71 shares of Amgen worth $22.7K as of Q3 2025.
  • WFA Asset Management bought 1 Amgen share in Q3 2025, an estimated $290.
  • Amgen made up 0.01% of WFA Asset Management's portfolio in Q3 2025, its #135 holding.
  • WFA Asset Management first reported a position in Amgen in Q4 2021 and has held it in 16 quarters since.
  • 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on WFA Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.